Protection of macaques against AIDS with a live attenuated SHIV vaccine is of finite duration

Virology

Volumn 371, Issue 2, 2008, Pages 238-245

  Kumar, Anil ^a   Liu, Zhenqian ^b   Sheffer, Darlene ^b   Smith, Marilyn ^b   Singh, Dinesh K ^d   Buch, Shilpa ^c   Narayan, Opendra ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d WINSTON SALEM STATE UNIVERSITY   (United States)

Author keywords

Attenuated virus; Challenge; Macaque; Protection; SHIV; SIV

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DNA DETERMINATION; DRUG EFFICACY; INOCULATION; MACACA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS REPLICATION;

AIDS VACCINES; ANIMALS; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV-1; MACACA MULATTA; RNA, VIRAL; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TIME FACTORS; VACCINATION; VACCINES, ATTENUATED;

ANIMALIA; MACACA; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 38649129878     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.10.008     Document Type: Article

References (33)

1. mac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. J. Virol. 77 5 (2003) 3099-3118
2. Amara R.R., Patel K., Niedziela G., Nigam P., Sharma S., Staprans S.I., Montefiori D.C., Chenareddi L., Herndon J.G., Robinson H.L., McClure H.M., and Novembre F.J. A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease. J. Virol. 79 24 (2005) 15356-15367
3. Baba T.W., Jeong Y.S., Pennick D., Bronson R., Greene M.F., and Ruprecht R.M. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267 5205 (1995) 1820-1825
4. Daniel M.D., Letvin N.L., King N.W., Kannagi M., Sehgal P.K., Hunt R.D., Kanki P.J., Essex M., and Desrosiers R.C. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228 4704 (1985) 1201-1204
5. Daniel M.D., Kirchhoff F., Czajak S.C., Sehgal P.K., and Desrosiers R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258 5090 (1992) 1938-1941
6. Desrosiers R.C. Will there be a live-attenuated HIV vaccine available for human safety trials by the year 2000? Interview by Gordon Nary. J. Int. Assoc. Physicians AIDS Care 4 11 (1998) 22-23
7. Douek D.C., Picker L.J., and Koup R.A. T cell dynamics in HIV-1 infection. Annu. Rev. Immunol. 21 (2003) 265-304
8. mac239. J. Virol. 79 12 (2005) 7707-7720
9. + T cell response by attenuated SIV infection. J. Exp. Med. 203 12 (2006) 2661-2672
10. Hu S.L. Non-human primate models for AIDS vaccine research. Curr. Drug Targets. Infect. Disord. 5 2 (2005) 193-201
11. Igarashi T., Endo Y., Englund G., Sadjadpour R., Matano T., Buckler C., Buckler-White A., Plishka R., Theodore T., Shibata R., and Martin M. Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus. Proc. Natl. Acad. Sci. U. S. A. 96 24 (1999) 14049-14054
12. + T cells and AIDS in pig-tailed macaques. J. Virol. 70 5 (1996) 3189-3197
13. + T cell loss and AIDS in rhesus macaques. J. Med. Primatol. 27 2-3 (1998) 59-64
14. Joag S.V., Liu Z.Q., Stephens E.B., Smith M.S., Kumar A., Li Z., Wang C., Sheffer D., Jia F., Foresman L., Adany I., Lifson J., McClure H.M., and Narayan O. Oral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS. J. Virol. 72 11 (1998) 9069-9078
15. Johnson R.P., and Desrosiers R.C. Protective immunity induced by live attenuated simian immunodeficiency virus. Curr. Opin. Immunol. 10 4 (1998) 436-443
16. Johnston M.I., and Fauci A.S. An HIV vaccine-evolving concepts. N. Engl. J. Med. 356 20 (2007) 2073-2081
17. Johnson R.P., Glickman R.L., Yang J.Q., Kaur A., Dion J.T., Mulligan M.J., and Desrosiers R.C. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J. Virol. 71 10 (1997) 7711-7718
18. Koff W.C., Johnson P.R., Watkins D.I., Burton D.R., Lifson J.D., Hasenkrug K.J., McDermott A.B., Schultz A., Zamb T.J., Boyle R., and Desrosiers R.C. HIV vaccine design: insights from live attenuated SIV vaccines. Nat. Immunol. 7 1 (2006) 19-23
19. Kumar A., Lifson J.D., Li Z., Jia F., Mukherjee S., Adany I., Liu Z., Piatak M., Sheffer D., McClure H.M., and Narayan O. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency virus (SHIV(89.6)P). Virology 279 1 (2001) 241-256
20. Kumar A., Mukherjee S., Shen J., Buch S., Li Z., Adany I., Liu Z., Zhuge W., Piatak Jr. M., Lifson J., McClure H., and Narayan O. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus. Virology 301 2 (2002) 189-205
21. Lassen K., Han Y., Zhou Y., Siliciano J., and Siliciano R.F. The multifactorial nature of HIV-1 latency. Trends Mol. Med. 10 11 (2004) 525-531
22. Luciw P.A., Pratt-Lowe E., Shaw K.E., Levy J.A., and Cheng-Mayer C. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc. Natl. Acad. Sci. U. S. A. 92 16 (1995) 7490-7494
23. Mackay G.A., Niu Y., Liu Z.Q., Mukherjee S., Li Z., Adany I., Buch S., Zhuge W., McClure H.M., Narayan O., and Smith M.S. Presence of intact vpu and nef genes in nonpathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques. Virology 295 1 (2002) 133-146
24. Mackay G.A., Liu Z., Singh D.K., Smith M.S., Mukherjee S., Sheffer D., Jia F., Adany I., Sun K.H., Dhillon S., Zhuge W., and Narayan O. Protection against late-onset AIDS in macaques prophylactically immunized with a live simian HIV vaccine was dependent on persistence of the vaccine virus. J. Immunol. 173 6 (2004) 4100-4107
25. Nickle D.C., Shriner D., Mittler J.E., Frenkel L.M., and Mullins J.I. Importance and detection of virus reservoirs and compartments of HIV infection. Curr. Opin. Microbiol. 6 4 (2003) 410-416
26. Pantaleo G., and Koup R.A. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat. Med. 10 8 (2004) 806-810
27. Reimann K.A., Li J.T., Veazey R., Halloran M., Park I.W., Karlsson G.B., Sodroski J., and Letvin N.L. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70 10 (1996) 6922-6928
28. Reimann K.A., Li J.T., Voss G., Lekutis C., Tenner-Racz K., Racz P., Lin W., Montefiori D.C., Lee-Parritz D.E., Lu Y., Collman R.G., Sodroski J., and Letvin N.L. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J. Virol. 70 5 (1996) 3198-3206
29. Sharma D.P., Zink M.C., Anderson M., Adams R., Clements J.E., Joag S.V., and Narayan O. Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques. J. Virol. 66 6 (1992) 3550-3556
30. Silverstein P.S., Mackay G.A., Mukherjee S., Li Z., Piatak Jr. M., Lifson J.D., Narayan O., and Kumar A. Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time. J. Virol. 74 22 (2000) 10489-10497
31. Smith M.S., Niu Y., Li Z., Adany I., Pinson D.M., Liu Z.Q., Berry T., Sheffer D., Jia F., and Narayan O. Systemic infection and limited replication of SHIV vaccine virus in brains of macaques inoculated intracerebrally with infectious viral DNA. Virology 301 1 (2002) 130-135
32. Wyand M.S., Manson K.H., Garcia-Moll M., Montefiori D., and Desrosiers R.C. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70 6 (1996) 3724-3733
33. Wyand M.S., Manson K., Montefiori D.C., Lifson J.D., Johnson R.P., and Desrosiers R.C. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J. Virol. 73 10 (1999) 8356-8363